T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

T. Rowe Price US Large Cap Growth Equity Fund A USD vs UBS Lux Equity Fund Biotech USD

1. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Verdipapir

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Gebyr

    1.59%

  • ISIN

    LU0174119429

  • Beholdninger

    10

2. UBS Lux Equity Fund Biotech USD

  • Verdipapir

    UBS Lux Equity Fund Biotech USD P-acc

  • Gebyr

    2.25%

  • ISIN

    LU0069152568

  • Beholdninger

    10

Fondsbeholdning

Vi har information om 20 beholdninger i T. Rowe Price US Large Cap Growth Equity Fund A USD, hvor den største beholdningen er Apple (9.76%), etterfulgt av Microsoft (9.54%) og Nvidia (8.54%). Sammenligner vi med UBS Lux Equity Fund Biotech USD har vi der 14 beholdninger hvor Regeneron Pharmaceuticals er største beholdningen (10.04%), etterfulgt av Vertex (9.9%) og Moderna (9.21%).

Alle beholdninger

Her sammenligner vi beholdningene i T. Rowe Price US Large Cap Growth Equity Fund A USD og UBS Lux Equity Fund Biotech USD.

T. Rowe Price US Large Cap Growth Equity Fund A USD UBS Lux Equity Fund Biotech USD
1. Apple Inc
USA
9.76 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Microsoft Corp
USA
9.54 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Nvidia Corp
USA
8.54 %
3. Moderna Inc
9.21 %
4. Amazon.com Inc
USA
8.24 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Alphabet Inc Class A
USA
4.52 %
5. AbbVie Inc
USA
5.52 %
6. Meta Platforms A
USA
4.47 %
6. Gilead Sciences Inc
USA
4.66 %
7. Mastercard Inc
USA
3.76 %
7. Amgen Inc
4.32 %
8. Intuit Inc
3.3 %
8. BioNTech SE
4.13 %
9. Visa Inc
USA
2.95 %
9. Karuna Therapeutics Inc
3.75 %
10. Fiserv Inc
2.64 %
10. Royalty Pharma Plc
3.28 %

Listen over fondsbeholdning ble sist oppdatert 29 april 2025.